Rezyrc Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
About Rezyrc Life Science
Rezyrc Life Science Private Limited (RLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 June 2018 (Six years and seven months 16 days old ). Its registered office is in Cuttack, Odisha, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shasikanta Das and Diptimayee Das serve as directors at the Company.
Company Details
-
Location
Cuttack, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999OR2018PTC029043
-
Company No.
029043
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jun 2018
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Rezyrc Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shasikanta Das
|
Managing Director | 18-Jun-2018 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Diptimayee Das
|
Director | 18-Jun-2018 | Current |
Financial Performance of Rezyrc Life Science.
Enhance accessibility to Rezyrc Life Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rezyrc Life Science?
Unlock access to Rezyrc Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Cryzer Formulation Private LimitedShasikanta Das and Diptimayee Das are mutual person
-
Cryzer Pharma Private Limited
Shasikanta Das is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rezyrc Life Science?
Unlock and access historical data on people associated with Rezyrc Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rezyrc Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rezyrc Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.